Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified FOLFOX6 and Bevacizumab in Advanced Biliary System Carcinoma
NCT00881504Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Jun 2009
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in biliary tract cancer (BTC), sponsored by Georgetown University. Started Jun 2009; status: terminated.
02
Drugs
bevacizumab
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00881504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00881504.